Skip to content

Hypoxia Blood Validation in Multiple Pulse Oximeters

Accuracy Validation in Multiple SpO2 Systems

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00881829
Enrollment
500
Registered
2009-04-15
Start date
2016-08-09
Completion date
2021-12-21
Last updated
2021-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia

Keywords

Pulse Oximetry, Temperature, Respiratory Rate, Respiratory Gases, This study determine the measurement accuracy of the physiological parameters

Brief summary

The purpose of this study is to evaluate the SpO2 accuracy and performance of multiple pulse oximeters during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry for SpO2 validation. This study is observational in nature which quantifies device performance and accuracy in comparison to a Reference Standard.

Detailed description

The purpose of this study is to evaluate the SpO2 accuracy and performance of pulse oximeters during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry for SpO2 validation. The end goal is to show the SpO2 accuracy performance of the pulse oximeters. It is expected that the Accuracy Root Mean Square (Arms) performance of pulse oximeters will meet a specification of 3 or better in non-motion conditions for the range of 70-100% SaO2 thereby demonstrating an acceptable SpO2 accuracy performance specification

Interventions

DEVICEPulse Oximeter, Blood Pressure, Respiratory Rate, Respiratory Gasses, Temperature

Measurement of physiological parameters.

Sponsors

Clinimark, LLC
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy individuals between the age of 18-50 years.

Exclusion criteria

* Clotting disorders, diabetes, currently taking psychotropic medications.

Design outcomes

Primary

MeasureTime frame
Completion of study by all subjects5 years

Countries

United States

Contacts

Primary ContactDena M Raley, BSBE
DMRaley@Clinimark.com303-249-6010
Backup ContactPaul B Batchelder, RRT
PBatchelder@Clinimark.com303-717-4820

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026